{"meshTags":["Antineoplastic Agents","Benzamides","Fluorodeoxyglucose F18","Gastrointestinal Stromal Tumors","Humans","Imatinib Mesylate","Male","Middle Aged","Piperazines","Positron-Emission Tomography","Pyrimidines","Radiopharmaceuticals"],"meshMinor":["Antineoplastic Agents","Benzamides","Fluorodeoxyglucose F18","Gastrointestinal Stromal Tumors","Humans","Imatinib Mesylate","Male","Middle Aged","Piperazines","Positron-Emission Tomography","Pyrimidines","Radiopharmaceuticals"],"publicationTypes":["Case Reports","Journal Article"],"title":"Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate.","pubmedId":"18287851"}